{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:58:31Z","timestamp":1793663911442,"version":"4.5.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS119263"],"award-info":[{"award-number":["R01NS119263"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS098772"],"award-info":[{"award-number":["R01NS098772"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS120663"],"award-info":[{"award-number":["R01NS120663"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62380-y","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T21:44:03Z","timestamp":1754603043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Anti-CV2\/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in rats"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7358-5335","authenticated-orcid":false,"given":"Laurent","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7021-853X","authenticated-orcid":false,"given":"Harrison J.","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyuba Y.","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-1366","authenticated-orcid":false,"given":"Nicolas LA.","family":"Dumaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1867-5041","authenticated-orcid":false,"given":"Kimberly","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Duy","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Loya-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5848-2458","authenticated-orcid":false,"given":"Cheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Calderon-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongzhi","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatrao","family":"Nunna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya S.","family":"Bellampalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liberty","family":"Fran\u00e7ois-Moutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohab","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Rogemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-5952","authenticated-orcid":false,"given":"J\u00e9r\u00f4me","family":"Honnorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9066-2969","authenticated-orcid":false,"given":"Rajesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-1206","authenticated-orcid":false,"given":"Aubin","family":"Moutal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"62380_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 15, 391\u2013404 (2016).","journal-title":"Lancet Neurol."},{"key":"62380_CR2","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","volume":"90","author":"D Dubey","year":"2018","unstructured":"Dubey, D. et al. Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases. Neurology 90, e103\u2013e110 (2018).","journal-title":"Neurology"},{"key":"62380_CR3","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1212\/WNL.0000000000008472","volume":"93","author":"D Dubey","year":"2019","unstructured":"Dubey, D. et al. Amphiphysin-IgG autoimmune neuropathy: a recognizable clinicopathologic syndrome. Neurology 93, e1873\u2013e1880 (2019).","journal-title":"Neurology"},{"key":"62380_CR4","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","volume":"49","author":"JC Antoine","year":"2001","unstructured":"Antoine, J. C. et al. Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann. Neurol. 49, 214\u2013221 (2001).","journal-title":"Ann. Neurol."},{"key":"62380_CR5","doi-asserted-by":"publisher","first-page":"4226","DOI":"10.1046\/j.1460-9568.1999.00864.x","volume":"11","author":"J Honnorat","year":"1999","unstructured":"Honnorat, J. et al. Ulip\/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur. J. Neurosci. 11, 4226\u20134232 (1999).","journal-title":"Eur. J. Neurosci."},{"key":"62380_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi, F. et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419\u2013430 (2010).","journal-title":"Lancet"},{"key":"62380_CR7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/ajmg.a.61069","volume":"179","author":"AM Kongkriangkai","year":"2019","unstructured":"Kongkriangkai, A. M. et al. Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1. Am. J. Med. Genet. A 179, 602\u2013607 (2019).","journal-title":"Am. J. Med. Genet. A"},{"key":"62380_CR8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","volume":"155","author":"M Seretny","year":"2014","unstructured":"Seretny, M. et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain 155, 2461\u20132470 (2014).","journal-title":"Pain"},{"key":"62380_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1385\/MN:28:1:51","volume":"28","author":"E Charrier","year":"2003","unstructured":"Charrier, E. et al. Collapsin response mediator proteins (CRMPs): involvement in nervous system development and adult neurodegenerative disorders. Mol. Neurobiol. 28, 51\u201364 (2003).","journal-title":"Mol. Neurobiol."},{"key":"62380_CR10","doi-asserted-by":"publisher","first-page":"37957","DOI":"10.1074\/jbc.M003277200","volume":"275","author":"M Fukada","year":"2000","unstructured":"Fukada, M. et al. Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family. J. Biol. Chem. 275, 37957\u201337965 (2000).","journal-title":"J. Biol. Chem."},{"key":"62380_CR11","doi-asserted-by":"publisher","first-page":"7203","DOI":"10.1523\/JNEUROSCI.21-18-07203.2001","volume":"21","author":"D Ricard","year":"2001","unstructured":"Ricard, D. et al. Isolation and expression pattern of human Unc-33-like phosphoprotein 6\/collapsin response mediator protein 5 (Ulip6\/CRMP5): coexistence with Ulip2\/CRMP2 in Sema3a- sensitive oligodendrocytes.  J. Neurosci. 21, 7203\u20137214 (2001).","journal-title":"J. Neurosci."},{"key":"62380_CR12","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1523\/JNEUROSCI.5337-10.2011","volume":"31","author":"N Yamashita","year":"2011","unstructured":"Yamashita, N. et al. CRMP5 (collapsin response mediator protein 5) regulates dendritic development and synaptic plasticity in the cerebellar Purkinje cells. J. Neurosci. 31, 1773\u20131779 (2011).","journal-title":"J. Neurosci."},{"key":"62380_CR13","doi-asserted-by":"publisher","first-page":"10639","DOI":"10.1523\/JNEUROSCI.0059-10.2010","volume":"30","author":"S Brot","year":"2010","unstructured":"Brot, S. et al. CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2. J. Neurosci. 30, 10639\u201310654 (2010).","journal-title":"J. Neurosci."},{"key":"62380_CR14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00005072-199804000-00002","volume":"57","author":"J Honnorat","year":"1998","unstructured":"Honnorat, J. et al. POP66, a paraneoplastic encephalomyelitis-related antigen, is a marker of adult oligodendrocytes. J. Neuropathol. Exp. Neurol. 57, 311\u2013322 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"62380_CR15","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","volume":"61","author":"J Honnorat","year":"1996","unstructured":"Honnorat, J., Antoine, J. C., Derrington, E., Aguera, M. & Belin, M. F. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 61, 270\u2013278 (1996).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"62380_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0169-328X(97)00080-6","volume":"46","author":"TT Quach","year":"1997","unstructured":"Quach, T. T. et al. Molecular cloning of a new unc-33-like cDNA from rat brain and its relation to paraneoplastic neurological syndromes. Brain Res. Mol. Brain Res. 46, 329\u2013332 (1997).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"62380_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","volume":"49","author":"Z Yu","year":"2001","unstructured":"Yu, Z. et al. CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann. Neurol. 49, 146\u2013154 (2001).","journal-title":"Ann. Neurol."},{"key":"62380_CR18","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41591-024-02839-5","volume":"30","author":"S Toikumo","year":"2024","unstructured":"Toikumo, S. et al. A multi-ancestry genetic study of pain intensity in 598,339 veterans. Nat. Med. 30, 1075\u20131084 (2024).","journal-title":"Nat. Med."},{"key":"62380_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nrn2947","volume":"11","author":"AJ Todd","year":"2010","unstructured":"Todd, A. J. Neuronal circuitry for pain processing in the dorsal horn. Nat. Rev. Neurosci. 11, 823\u2013836 (2010).","journal-title":"Nat. Rev. Neurosci."},{"key":"62380_CR20","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1097\/PAS.0b013e31817dc37c","volume":"32","author":"D Meyronet","year":"2008","unstructured":"Meyronet, D. et al. Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma. Am. J. Surg. Pathol. 32, 1699\u20131708 (2008).","journal-title":"Am. J. Surg. Pathol."},{"key":"62380_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/cpcb.115","volume":"89","author":"M Hegazy","year":"2020","unstructured":"Hegazy, M. et al. Proximity ligation assay for detecting protein-protein interactions and protein modifications in cells and tissues in situ. Curr. Protoc. Cell Biol. 89, e115 (2020).","journal-title":"Curr. Protoc. Cell Biol."},{"key":"62380_CR22","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1097\/j.pain.0000000000000555","volume":"157","author":"A Moutal","year":"2016","unstructured":"Moutal, A. et al. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology. Pain 157, 1448\u20131463 (2016).","journal-title":"Pain"},{"key":"62380_CR23","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1073\/pnas.1324019111","volume":"111","author":"RW Teichert","year":"2014","unstructured":"Teichert, R. W., Memon, T., Aman, J. W. & Olivera, B. M. Using constellation pharmacology to define comprehensively a somatosensory neuronal subclass. Proc. Natl. Acad. Sci. USA 111, 2319\u20132324 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62380_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.jpain.2022.02.009","volume":"23","author":"RY North","year":"2022","unstructured":"North, R. Y. et al. Electrophysiological alterations driving pain-associated spontaneous activity in human sensory neuron somata parallel alterations described in spontaneously active rodent nociceptors. J. Pain 23, 1343\u20131357 (2022).","journal-title":"J. Pain"},{"key":"62380_CR25","doi-asserted-by":"publisher","first-page":"14870","DOI":"10.1523\/JNEUROSCI.2428-10.2010","volume":"30","author":"SS Bedi","year":"2010","unstructured":"Bedi, S. S. et al. Chronic spontaneous activity generated in the somata of primary nociceptors is associated with pain-related behavior after spinal cord injury. J. Neurosci. 30, 14870\u201314882 (2010).","journal-title":"J. Neurosci."},{"key":"62380_CR26","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1097\/j.pain.0000000000001002","volume":"158","author":"A Moutal","year":"2017","unstructured":"Moutal, A. et al. CRISPR\/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide. Pain 158, 2301\u20132319 (2017).","journal-title":"Pain"},{"key":"62380_CR27","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","volume":"13","author":"TS Jensen","year":"2014","unstructured":"Jensen, T. S. & Finnerup, N. B. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 13, 924\u2013935 (2014).","journal-title":"Lancet Neurol."},{"key":"62380_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrneurol.2013.180","volume":"9","author":"A Truini","year":"2013","unstructured":"Truini, A., Garcia-Larrea, L. & Cruccu, G. Reappraising neuropathic pain in humans-how symptoms help disclose mechanisms. Nat. Rev. Neurol. 9, 572\u2013582 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"62380_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/jnc.12188","volume":"125","author":"R Ponnusamy","year":"2013","unstructured":"Ponnusamy, R. & Lohkamp, B. Insights into the oligomerization of CRMPs: crystal structure of human collapsin response mediator protein 5. J. Neurochem 125, 855\u2013868 (2013).","journal-title":"J. Neurochem"},{"key":"62380_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12311-023-01524-6","volume":"23","author":"F Faure","year":"2024","unstructured":"Faure, F. et al. A pilot study to develop paraneoplastic cerebellar degeneration mouse model. Cerebellum 23, 181\u2013196 (2024).","journal-title":"Cerebellum"},{"key":"62380_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0303-8467(95)00006-6","volume":"97","author":"K Tanaka","year":"1995","unstructured":"Tanaka, K. et al. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice. Clin. Neurol. Neurosurg. 97, 101\u2013105 (1995).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"62380_CR32","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff, J. A. et al. Direct gene transfer into mouse muscle in vivo. Science 247, 1465\u20131468 (1990).","journal-title":"Science"},{"key":"62380_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16505-0","volume":"11","author":"TRF Smith","year":"2020","unstructured":"Smith, T. R. F. et al. Immunogenicity of a DNA vaccine candidate for COVID-19. Nat. Commun. 11, 2601 (2020).","journal-title":"Nat. Commun."},{"key":"62380_CR34","doi-asserted-by":"publisher","first-page":"e0150164","DOI":"10.1371\/journal.pone.0150164","volume":"11","author":"SE Harte","year":"2016","unstructured":"Harte, S. E., Meyers, J. B., Donahue, R. R., Taylor, B. K. & Morrow, T. J. Mechanical conflict system: a novel operant method for the assessment of nociceptive behavior. PLoS ONE 11, e0150164 (2016).","journal-title":"PLoS ONE"},{"key":"62380_CR35","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jpain.2019.04.008","volume":"20","author":"R Khanna","year":"2019","unstructured":"Khanna, R. et al. Development and characterization of an injury-free model of functional pain in rats by exposure to red light. J. Pain 20, 1293\u20131306 (2019).","journal-title":"J. Pain"},{"key":"62380_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11095-011-0578-3","volume":"29","author":"L Kagan","year":"2012","unstructured":"Kagan, L., Turner, M. R., Balu-Iyer, S. V. & Mager, D. E. Subcutaneous absorption of monoclonal antibodies: role of dose, site of injection, and injection volume on rituximab pharmacokinetics in rats. Pharm. Res. 29, 490\u2013499 (2012).","journal-title":"Pharm. Res."},{"key":"62380_CR37","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302259RR","volume":"38","author":"A Mostkowska","year":"2024","unstructured":"Mostkowska, A., Rousseau, G. & Raynal, N. J. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases. FASEB J. 38, e23536 (2024).","journal-title":"FASEB J."},{"key":"62380_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/ncpneuro0901","volume":"4","author":"MC Dalakas","year":"2008","unstructured":"Dalakas, M. C. B cells as therapeutic targets in autoimmune neurological disorders. Nat. Clin. Pract. Neurol. 4, 557\u2013567 (2008).","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"62380_CR39","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1158\/0008-5472.CAN-14-0631","volume":"75","author":"A Moutal","year":"2015","unstructured":"Moutal, A. et al. CRMP5 controls glioblastoma cell proliferation and survival through notch-dependent signaling. Cancer Res. 75, 3519\u20133528 (2015).","journal-title":"Cancer Res."},{"key":"62380_CR40","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neurol.2014.07.002","volume":"170","author":"JC Antoine","year":"2014","unstructured":"Antoine, J. C. Peripheral neuropathies associated with antibodies directed to intracellular neural antigens. Rev. Neurol. 170, 570\u2013576 (2014).","journal-title":"Rev. Neurol."},{"key":"62380_CR41","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/intimm\/12.4.415","volume":"12","author":"SX Deng","year":"2000","unstructured":"Deng, S. X., Hanson, E. & Sanz, I. In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies. Int. Immunol. 12, 415\u2013423 (2000).","journal-title":"Int. Immunol."},{"key":"62380_CR42","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1212\/WNL.41.11.1757","volume":"41","author":"J Dalmau","year":"1991","unstructured":"Dalmau, J., Furneaux, H. M., Rosenblum, M. K., Graus, F. & Posner, J. B. Detection of the anti-Hu antibody in specific regions of the nervous system and tumor from patients with paraneoplastic encephalomyelitis\/sensory neuronopathy. Neurology 41, 1757\u20131764 (1991).","journal-title":"Neurology"},{"key":"62380_CR43","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1212\/WNL.37.11.1780","volume":"37","author":"RH Fabian","year":"1987","unstructured":"Fabian, R. H. & Petroff, G. Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology 37, 1780\u20131784 (1987).","journal-title":"Neurology"},{"key":"62380_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/BF00812161","volume":"239","author":"M Drlicek","year":"1992","unstructured":"Drlicek, M. et al. Circulating antineuronal antibodies reach neurons in vivo: an autopsy study. J. Neurol. 239, 407\u2013410 (1992).","journal-title":"J. Neurol."},{"key":"62380_CR45","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3389\/fimmu.2018.00638","volume":"9","author":"M Gunasekaran","year":"2018","unstructured":"Gunasekaran, M. et al. Immunization elicits antigen-specific antibody sequestration in dorsal root ganglia sensory neurons. Front. Immunol. 9, 638 (2018).","journal-title":"Front. Immunol."},{"key":"62380_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217800120","volume":"120","author":"K Gomez","year":"2023","unstructured":"Gomez, K. et al. Identification and targeting of a unique Na(V)1.7 domain driving chronic pain. Proc. Natl. Acad. Sci. USA 120, e2217800120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62380_CR47","doi-asserted-by":"publisher","first-page":"6736","DOI":"10.1007\/s12035-019-1568-4","volume":"56","author":"A Moutal","year":"2019","unstructured":"Moutal, A. et al. Dysregulation of CRMP2 post-translational modifications drive its pathological functions. Mol. Neurobiol. 56, 6736\u20136755 (2019).","journal-title":"Mol. Neurobiol."},{"key":"62380_CR48","doi-asserted-by":"publisher","first-page":"E8443","DOI":"10.1073\/pnas.1610531113","volume":"113","author":"ET Dustrude","year":"2016","unstructured":"Dustrude, E. T. et al. Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proc. Natl. Acad. Sci. USA 113, E8443\u2013E8452 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"62380_CR49","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1038\/mp.2017.117","volume":"23","author":"A Moutal","year":"2018","unstructured":"Moutal, A. et al. Blocking CRMP2 SUMOylation reverses neuropathic pain. Mol. Psychiatry 23, 2119\u20132121 (2018).","journal-title":"Mol. Psychiatry"},{"key":"62380_CR50","doi-asserted-by":"crossref","unstructured":"Moutal, A., Luo, S., Largent-Milnes, T. M., Vanderah, T. W. & Khanna, R. Cdk5-mediated CRMP2 phosphorylation is necessary and sufficient for peripheral neuropathic pain. Neurobiol. Pain 5, 100022 (2019).","DOI":"10.1016\/j.ynpai.2018.07.003"},{"key":"62380_CR51","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin, P. et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J. Clin. Oncol. 16, 2825\u20132833 (1998).","journal-title":"J. Clin. Oncol."},{"key":"62380_CR52","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1182\/blood.V84.8.2457.2457","volume":"84","author":"DG Maloney","year":"1994","unstructured":"Maloney, D. G. et al. Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma. Blood 84, 2457\u20132466 (1994).","journal-title":"Blood"},{"key":"62380_CR53","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1002\/art.23059","volume":"56","author":"E Keystone","year":"2007","unstructured":"Keystone, E. et al. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis. Arthritis Rheumatol. 56, 3896\u20133908 (2007).","journal-title":"Arthritis Rheumatol."},{"key":"62380_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","volume":"48","author":"SF Bomholt","year":"2005","unstructured":"Bomholt, S. F., Mikkelsen, J. D. & Blackburn-Munro, G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology 48, 252\u2013263 (2005).","journal-title":"Neuropharmacology"},{"key":"62380_CR55","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pain.2004.08.004","volume":"112","author":"J Fernihough","year":"2004","unstructured":"Fernihough, J. et al. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain 112, 83\u201393 (2004).","journal-title":"Pain"},{"key":"62380_CR56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1124\/jpet.104.070656","volume":"311","author":"S Iyengar","year":"2004","unstructured":"Iyengar, S., Webster, A. A., Hemrick-Luecke, S. K., Xu, J. Y. & Simmons, R. M. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J. Pharmacol. Exp. Ther. 311, 576\u2013584 (2004).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"62380_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-2999(97)00070-8","volume":"324","author":"JC Hunter","year":"1997","unstructured":"Hunter, J. C. et al. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324, 153\u2013160 (1997).","journal-title":"Eur. J. Pharmacol."},{"key":"62380_CR58","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.pain.2003.12.028","volume":"109","author":"M Millecamps","year":"2004","unstructured":"Millecamps, M., Etienne, M., Jourdan, D., Eschalier, A. & Ardid, D. Decrease in non-selective, non-sustained attention induced by a chronic visceral inflammatory state as a new pain evaluation in rats. Pain 109, 214\u2013224 (2004).","journal-title":"Pain"},{"key":"62380_CR59","doi-asserted-by":"crossref","unstructured":"Fran\u00e7ois-Moutal, L. et al. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. Pain 156, 1247\u20131264 (2015).","DOI":"10.1097\/j.pain.0000000000000147"},{"key":"62380_CR60","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","volume":"17","author":"TL Yaksh","year":"1976","unstructured":"Yaksh, T. L. & Rudy, T. A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17, 1031\u20131036 (1976).","journal-title":"Physiol. Behav."},{"key":"62380_CR61","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","volume":"53","author":"SR Chaplan","year":"1994","unstructured":"Chaplan, S. R., Bach, F. W., Pogrel, J. W., Chung, J. M. & Yaksh, T. L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53, 55\u201363 (1994).","journal-title":"J. Neurosci. Methods"},{"key":"62380_CR62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","volume":"32","author":"K Hargreaves","year":"1988","unstructured":"Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32, 77\u201388 (1988).","journal-title":"Pain"},{"key":"62380_CR63","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1126\/science.8456302","volume":"259","author":"JB Ulmer","year":"1993","unstructured":"Ulmer, J. B. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745\u20131749 (1993).","journal-title":"Science"},{"key":"62380_CR64","doi-asserted-by":"publisher","first-page":"67901","DOI":"10.18632\/oncotarget.12178","volume":"7","author":"VT Colluru","year":"2016","unstructured":"Colluru, V. T. & McNeel, D. G. B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines. Oncotarget 7, 67901\u201367918 (2016).","journal-title":"Oncotarget"},{"key":"62380_CR65","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1182\/blood-2008-06-165803","volume":"112","author":"R Geiben-Lynn","year":"2008","unstructured":"Geiben-Lynn, R. et al. CD4+ T lymphocytes mediate in vivo clearance of plasmid DNA vaccine antigen expression and potentiate CD8+ T-cell immune responses. Blood 112, 4585\u20134590 (2008).","journal-title":"Blood"},{"key":"62380_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virol.2012.01.001","volume":"425","author":"G Khawaja","year":"2012","unstructured":"Khawaja, G. et al. Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation. Virology 425, 61\u201369 (2012).","journal-title":"Virology"},{"key":"62380_CR67","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8","volume":"28","author":"T Sparwasser","year":"1998","unstructured":"Sparwasser, T. et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045\u20132054 (1998).","journal-title":"Eur. J. Immunol."},{"key":"62380_CR68","first-page":"71","volume":"29","author":"HL Davis","year":"2000","unstructured":"Davis, H. L. Intramuscular and intradermal injection of DNA vaccines in mice and primates. Methods Mol. Med. 29, 71\u201377 (2000).","journal-title":"Methods Mol. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62380-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62380-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62380-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:59:15Z","timestamp":1757361555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62380-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62380"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62380-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"7 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7311"}}